Skip to content

Effects of Pericapsular Nerve Group Block on Postoperative Recovery for Total Hip Arthroplasty

Effects of Pericapsular Nerve Group Block on Postoperative Recovery for Total Hip Arthroplasty

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06183528
Enrollment
60
Registered
2023-12-27
Start date
2023-09-01
Completion date
2025-12-30
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Postoperative Pain, Acute

Keywords

Multimodal analgesia, pericapsular nerve group block, total hip arthroplasty, spinal anesthesia

Brief summary

The hypothesis of this study is that patients who undergo PENG block in before Total Hip Artroplasthy (THA) surgery with spinal anesthesia will have reduced postoperative pain scores, less need for opioid analgesics and earlier mobilisation.

Detailed description

This prospective randomised controlled study included a total of 60 patients aged 40-85 years who underwent THA surgery under spinal anaesthesia. Patients were divided into two groups as PENG block (n:30) and non-PENG block (n:30). PENG block was placed in the fascial plane between the pseudotendon and pubic ramus with USG in-plane technique, 20 ml of 0.5% bupivacaine was administered and surgery was initiated. The primary outcome of the study was to investigate the effect of preoperative PENG block application on postoperative pain, opioid requirement, mobilisation time, hip joint patency and length of hospital stay in patients undergoing THA surgery. The secondary outcome was to investigate the effect of PENG block on perioperative haemodynamics and postoperative side effects. For multimodal analgesia, 10 ml 0.5% bupivacaine + 10 ml 2% lidocaine is infiltrated into the surgical wound incision line by the surgical team at the end of surgery. After tramadol 50 mg loading with PCA device, a basal rate of 5-10 mg/hour (20 mg bolus dose + 30 minutes lock time) is given with paracetamol 10 mg/kg iv (8 hours interval).

Interventions

PROCEDUREPericapsular Nerve Group (PENG) Block

With ultrasonography-guided PENG block, the femoral, obturator and accessory obturator nerve branches that provide sensory innervation of the anterior surface of the hip joint capsule are blocked .

Sponsors

Umraniye Education and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

This prospective randomised controlled study included a total of 60 patients aged 40-85 years who underwent THA surgery under spinal anaesthesia. Patients were divided into two groups as PENG block and non-PENG block (control group).

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* THA performed by posterior approach * 40-85 age range * ASA 1-3

Exclusion criteria

Under 40 years of age, over 85 years of age, * ASA 4 and above, * Cognitive impairment (Alzheimer's disease, dementia, delirium etc.), * Hip fracture, * Application site infection, * Allergy to local anaesthetic agents, * Patients are non-consenting patients.

Design outcomes

Primary

MeasureTime frameDescription
postoperative pain scorerecovery room 30 min, 12., 24. and 48. hours in the postoperative periodVAS pain score
mobilisation time24 -48 hourswalking 5 steps with walker
hip joint patency24. hoursMeasurement of joint movement angle with goniometer (angle)
total opioid consumption48 hoursTramadol total usage (mg)

Secondary

MeasureTime frameDescription
Perioperative haemodynamic dataT1: 30 minutes (min) after spinal anesthesia, T2: at the end of the surgical procedure, T3: at 30 minutes after recoveryheart rate, mean arterial pressure
length of hospital staydayhospitalization and discharge time for surgery
PENG block side effectsThe first 48 hours after performing the PENG blockmotor block, nausea, vomiting, anaphylaxis, nerve damage

Countries

Turkey (Türkiye)

Contacts

Primary Contactzeliha tuncel, ass prof
zelihalara@yahoo.com+905053577483
Backup Contacthale arkan tuna, specialist dr
halearkan@yahoo.com.tr+905303705619

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026